［1］ALLAHVERDIYEV A,TARI G,BAGIROVA M,et al.Current approaches in development of immunotherapeutic vaccines for breast cancer［J］.J Breast Cancer,2018,21:343-353.
［2］KELLER S,RIDINGER J,RUPP AK,et al.Body fluid derived exosomes as a novel template for clinical diagnostics［J］.J Transl Med，2011,9(1):86.
［3］CABY MP,LANKAR D,VINCENDEAU-SCHERRER C,et al.Exosomal-like vesicles are present in human blood plasma［J］.Int Immunol,2005,17(7):879-887.
［4］ADMYRE C,JOHANSSON SM,QAZI KR,et al.Exosomes with immune modulatory features are present in human breast milk［J］.J Immunol,2007,179(3):1969-1978.
［5］SANCHEZ-VIDAURRE S,ELDH M,LARSSEN P,et al.RNA-containing exosomes in induced sputum of asthmatic patients［J］.J Allergy Clin Immunol,2017,140(5):1459-1461.
［6］NILSSON J,SKOG J,NORDSTRAND A,et al.Prostate cancer-derived urine exosomes:a novel approach to biomarkers for prostate cancer［J］.Br J Cancer,2009,100(10):1603.
［7］COLOMBO M,RAPOSO G,THERY C.Biogenesis,secretion,and intercellular interactions of exosomes and other extracellular vesicles［J］.Annu Rev Cell Dev Biol,2014,30:255-289.
［8］MATHIVANAN S,JI H,SIMPSON RJ.Exosomes:extracellular organelles important in intercellular communication［J］.J Proteomics,2010,73(10):1907-1920.
［9］KOWAL J,TKACH M,THERY C.Biogenesis and secretion of exosomes［J］.Curr Opin Cell Biol,2014,29:116-125.
［10］NASERI M,BOZORGMEHR M,ZOLLER M,et al.Tumor-derived exosomes:the next generation of promising cell-free vaccines in cancer immunotherapy［J］.Oncoimmunology,2020,9(1):1779991.
［11］PETRIK J.Immunomodulatory effects of exosomes produced by virus-infected cells［J］.Transfus Apher Sci,2016,55(1):84-91.
［12］SCHOREY JS,CHENG Y,SINGH PP,et al.Exosomes and other extracellular vesicles in host-pathogen interactions［J］.EMBO Rep,2015,16(1):24-43.
［13］ASSIL S,WEBSTER B,DREUX M.Regulation of the host antiviral state by intercellular communications［J］.Viruses,2015,7(8):4707-4733.
［14］VALADI H,EKSTROM K,BOSSIOS A,et al.Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells［J］.Nat Cell Biol,2007,9(6):654-659.
［15］RAAB-TRAUB N,DITTMER DP.Viral effects on the content and function of extracellular vesicles［J］.Nat Rev Microbiol,2017,15(9):559-572.
［16］WOLFERS J,LOZIER A,RAPOSO G,et al.Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming［J］.Nat Med,2001,7(3):297-303.
［17］ANDRE F,SCHARTZ NEC,CHAPUT N,et al.Tumor-derived exosomes:a new source of tumor rejection antigens［J］.Vaccine,2002,20(suppl_4):A28-31.
［18］SYN N,WANG L,SETHI G,et al.Exosome mediated metastasis:from epithelial-mesenchymal transition to escape from immunosurveillance［J］.Trends Pharmacol Sci,2016,37(7):606-617.
［19］JOHNSEN KB,GUDBERGSSON JM,SKOV MN,et al.A comprehensive overview of exosomes as drug delivery vehicles-endogenous nanocarriers for targeted cancer therapy［J］.Biochim Biophys Acta,2014,1846(1):75-87.
［20］CHEN L,CHARRIER A,ZHOU Y,et al.Epigenetic regulation of connective tissue growth factor by microRNA-214 delivery in exosomes from mouse or human hepatic stellate cells［J］.Hepatology,2014,59(3):1118-1129.
［21］HANEY MJ,KLYACHKO NL,ZHAO Y,et al.Exosomes as drug delivery vehicles for Parkinson's disease therapy［J］.J Control Release,2015,207:18-30.
［22］PETROS RA,DESIMONE JM.Strategies in the design of nanoparticles for therapeutic applications［J］.Nat Rev Drug Discov,2010,9(8):615-627.
［23］RIEHEMANN K,SCHNEIDER SW,LUGER TA,et al.Nanomedicine-challenge and perspectives［J］.Angew Chem Int Ed Engl,2009,48(5):872-897.
［24］SALAZAR-GONZALEZ JA,GONZALEZ-ORTEGA O,ROSALES-MENDOZA S.Gold nanoparticles and vaccine development［J］.Expert Rev Vaccines,2015,14(9):1197-1211.
［25］CHAPUT N,SCHARTZ NEC,ANDRE F,et al.Exosomes as potent cell-free peptide-based vaccine.Ⅱ.Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection［J］.J Immunol,2004,172:2137-2146.
［26］LAMPARSKI HG,METHA-DAMANI A,YAO JY,et al.Production and characterization of clinical grade exosomes derived from dendritic cells［J］.J Immunol Methods,2002,270:211-226.
［27］DAI S,WEI D,WU Z,et al.Phase Ⅰ clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer［J］.Mol Ther,2008,16:782-790.
［28］WYSOCZYNSKI M,RATAJCZAK MZ.Lung cancer secreted microvesicles:underappreciated modulators of microenvironment in expanding tumors［J］.Int J Cancer,2009,125:1595-1603.
［29］ZHANG HC,LIU XB,HUANG S,et al.Microvesicles derived from human umbilical cord mesenchymal stem cells stimulated by hypoxia promote angiogenesis both in vitro and in vivo［J］.Stem Cells Dev,2012,21:3289-3297.
［30］KING HW,MICHAEL MZ,GLEADLE JM.Hypoxic enhancement of exosome release by breast cancer cells［J］.BMC Cancer,2012,12:421.
［31］PAROLINI I,FEDERICI C,RAGGI C,et al.Microenvironmental pH is a key factor for exosome traffic in tumor cells［J］.J Biol Chem,2009,284:34211-34222.
［32］LYU LH,WAN YL,LIN Y,et al.Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro［J］.J Biol Chem,2012,287:15874-15885.
［33］SAMUEL P,MULCAHY LA,FURLONG F,et al.Cisplatin induces the release of extracellular vesicles from ovarian cancer cells that can induce invasiveness and drug resistance in bystander cells［J］.Philos Trans R Soc Lond B Biol Sci,2018,373(1737):20170065.
［34］KOSGODAGE US,TRINDADE RP,THOMPSON PR,et al.Chloramidine/Bisindolylmaleimide-Ⅰ-mediated inhibition of exosome and microvesicle release and enhanced efficacy of cancer chemotherapy［J］.Int J Mol Sci,2017,18(5):1007.
［35］BANDARI SK,PURUSHOTHAMAN A,RAMANI VC,et al.Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior［J］.Matrix Biol,2018,65:104-118.
［36］PATEL GK,KHAN MA,BNARDWAJ A,et al.Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme,DCK［J］.Br J Cancer,2017,116(5):609-619.
［37］CHEN T,GUO J,HAN C,et al.Heat shock protein 70,released from heat-stressed tumor cells,initiates antitumor immunity by inducing tumor cell chemokine production and activating dendritic cells via TLR4 pathway［J］.J Immunol,2009,182(3):1449-1459.
［38］ELDH M,EKSTROM K,VALADI H,et al.Exosomes communicate protective messages during oxidative stress;possible role of exosomal shuttle RNA［J］.PLoS One,2010,5(12):e15353.
［39］HEDLUND M,NAGAEVA O,KARGL D,et al.Thermal-andoxidative stress causes enhanced release of NKG2D ligand-bearing immunosuppressive exosomes in leukemia/lymphoma T and B cells［J］.PLoS One,2011,6:e16899.
［40］CHEN T,GUO J,YANG M,et al.Chemokine-containing exosomes are released from heat-stressed tumor cells via lipid raft-dependent pathway andact as efficient tumor vaccine［J］.J Immunol,2011,186:2219-2228.
［41］COCOZZA F,MENAY F,TSACALIAN R,et al.Cyclophosphamide enhances the release of tumor exosomes that elicit a specific immune response in vivo in a murine T-cell lymphoma［J］.Vaccine,2019,37(12):1565-1576.
［42］KIM WS,CHOI D,PARK JM,et al.Comparison of exosomes derived from non-and gamma-irradiated melanoma cancer cells as a potential antigenic and immunogenic source for dendritic cell-based immunotherapeutic vaccine［J］.Vaccines(Basel),2020,8(4):699.
［43］JELLA KK,NASTI TH,LI Z,et al.Exosome-containing preparations from post irradiated mouse melanoma cells delay melanoma growth in vivo by a natural killer cell-dependent mechanism［J］.Int J Radiat Oncol Biol Phys,2020,108(1):104-114.
［44］YANG Y,CHEN Y,ZHANG F,et al.Increased anti-tumour activity by exosomes derived from doxorubicin-treated tumour cells via heat stress［J］.Int J Hyperthermia,2015,31:498-506.
［45］MIGNOT G,ROUX S,THERY C,et al.Prospects for exosomes in immunotherapy of cancer［J］.J Cell Mol Med,2006,10:376-388.
［46］KIM SH,BIANCO N,MENON R,et al.Exosomes derived from genetically modified DC expressing FasL are anti inflammatory and immunosuppressive［J］.Mol Ther,2006,13:289-300.
［47］DELCAYRE A,LE PECQ JB.Exosomes as novel therapeutic nanodevices［J］.Curr Opin Mol Ther,2006,8:31-38.
［48］ZITVOGEL L,REGAULT A,LOZIER A,et al.Eradication of established murine tumors using a novel cell-free vaccine:dendritic cell derived exosomes［J］.Nat Med,1998,4:594-600.
［49］CLAYTON A,TABI Z.Exosomes and the MICA-NKG2D system in cancer［J］.Blood Cell Mol Dis,2005,34:206-213.
［50］NASERI M,BOZORGMEHR M,ZOLLER M,et al.Tumor-derived exosomes:the next generation of promising cell-free vaccines in cancer immunotherapy［J］.Oncoimmunology,2020,9(1):1779991.
［51］HUANG F,LI Z,ZHANG W,et al.Enhancing the anti-leukemia immunity of acute lymphocytic leukemia-derived exosome-based vaccine by downregulation of PD-L1 expression［J］.Cancer Immunol Immunother,2022,71(9):2197-2212.
［52］TAGHIKHANI A,HASSAN ZM,EBRAHIMI M,et al.microRNA modified tumor-derived exosomes as novel tools for maturation of dendritic cells［J］.J Cell Physiol,2019,234(6):9417-9427.
［53］LEE YS,KIM SH,CHO JA,et al.Introduction of the CIITA gene into tumor cells produces exosomes with enhanced anti-tumor effects［J］.Exp Mol Med,2011,43(5):281-290.
［54］YILDIRIM M,YILDIRIM TC,TURAY N,et al.TLR ligand loaded exosome mediated immunotherapy of established mammary tumor in mice［J］.Immunol Lett,2021,239:32-41.
［55］HU S,MA J,SU C,et al.Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis［J］.Acta Biomater,2021,135:567-581.
［56］VIAUD S,THERY C,PLOIX S,et al.Dendritic cell-derived exosomes for cancer immunotherapy:what's next［J］.Cancer Res,2010,70(4):1281-1285.
［57］ZITVOGEL L,REGAULT A,LOZIER A,et al.Eradication of established murine tumors using a novel cell-free vaccine:dendritic cell-derived exosomes［J］.Nat Med,1998,4(5):594-600.
［58］PITT JM,ANDRE F,AMIGORENA S,et al.Dendritic cell-derived exosomes for cancer therapy［J］.J Clin Invest,2016,126(4):1224-1232.
［59］LU Z,ZUO B,JING R,et al.Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models［J］.J Hepatol,2017,67(4):739-748.
［60］LI J,LI J,PENG Y,et al.Dendritic cell derived exosomes loaded neoantigens for personalized cancer immunotherapies［J］.J Control Release,2023,353:423-433.
［61］CHENG L,WANG Y,HUANG L.Exosomes from M1-polarized macrophages potentiate the cancer vaccine by creating a pro-inflammatory microenvironment in the lymph node［J］.Mol Ther,2017,25(7):1665-1675.
［62］ZHAO G,LIU H,WANG Z,et al.Exosome transportation-mediated immunosuppression relief through cascade amplification for enhanced apoptotic body vaccination［J］.Acta Biomater,2022,153:529-539.
［63］STONEHILL EH,BENDICH A.Retrogenetic expression:the reappearance of embryonal antigens in cancer cells［J］.Nature,1970,228(5269):370-372.
［64］HALL C,CLARKE L,PAL A,et al.A review of the role of carcinoembryonic antigen in clinical practice［J］.Ann Coloproctol,2019,35(6):294-305.
［65］MENG S,WHITT AG,STAMP BF,et al.Exosome-based cancer vaccine for prevention of lung cancer［J］.Stem Cell Investig,2023,10:2.
［66］WANG R,ZHU T,HOU B,et al.An iPSC-derived exosome-pulsed dendritic cell vaccine boosts antitumor immunity in melanoma［J］.Mol Ther,2023,31(8):2376-2390.
［67］DI BONITO P,ACCARDI L,GALATI L,et al.Anti-cancer vaccine for HPV-associated neoplasms:Focus on a therapeutic HPV vaccine based on a novel tumor antigen delivery method using endogenously engineered exosomes［J］.Cancers(Basel),2019,11(2):138.
［68］XU J,LIU H,WANG T,et al.CCR7 mediated,mimetic dendritic cell vaccine homing in lymph node for head and neck squamous cell carcinoma therapy［J］.Adv Sci,2023,10(17):e2207017.
［69］WANG S,LI F,YE T,et al.Macrophage-tumor chimeric exosomes accumulate in lymph node and tumor to activate the immune response and the tumor microenvironment［J］.Sci Transl Med,2021,13(615):eabb6981.
［70］ZHONG X,ZHOU Y,CAO Y,et al.Enhanced antitumor efficacy through microwave ablation combined with a dendritic cell-derived exosome vaccine in hepatocellular carcinoma［J］.Int J Hyperthermia,2020,37(1):1210-1218.
［71］GUO F,CHANG CK,FAN HH,et al.Anti-tumour effects of exosomes in combination with cyclophosphamide and polyinosinic-polycytidylic acid［J］.J Int Med Res,2008,36(6):1342-1353.
［72］XU HY,LI N,YAO N,et al.CD8+T cells stimulated by exosomes derived from RenCa cells mediate specific immune responses through the FasL/Fas signaling pathway and,combined with GM CSF and IL 12,enhance the anti renal cortical adenocarcinoma effect［J］.Oncol Rep,2019,42(2):866-879.
［73］SHI MM,YANG QY,MONSEL A,et al.Preclinical efficacy and clinical safety of clinical-grade nebulized allogenic adipose mesenchymal stromal cells-derived extracellular vesicles［J］.J Extracell Vesicles,2021,10(10):e12134.
［74］ESCUDIER B,DORVAL T,CHAPUT N,et al.Vaccination of metastatic melanoma patients with autologous dendritic cell(DC) derived-exosomes:results of the first phase Ⅰ clinical trial［J］.J Transl Med,2005,3(1):10.
［75］DAI S,WEI D,WU Z,et al.Phase Ⅰ clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer［J］.Mol Ther,2008,16(4):782-790.
［76］MICHAEL AM,JENNIFER G,TAKUYA O,et al.A phase Ⅰ study of dexosome immunotherapy in patients with advanced non-small cell lung cancer［J］.Journal of Translational Medicine,2005,3(1):9.
［77］VIAUD S,TERME M,FLAMENT C,et al.Dendritic cell-derived exosomes promote natural killer cell activation and proliferation:a role for NKG2D ligands and IL-15R alpha［J］.PLoS One,2009,4:e4942.
［78］JANG SC,KIM OY,YOON CM,et al.Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors［J］.ACS Nano,2013,7(9):7698-7710.
［79］XU Z,ZENG S,GONG Z,et al.Exosome-based immunotherapy:a promising approach for cancer treatment［J］.Mol Cancer,2020,19(1):160.
［80］HUDA MN,NURUNNABI M.Potential application of exosomes in vaccine development and delivery［J］.Pharm Res,2022,39(11):2635-2671.